EconPapers    
Economics at your fingertips  
 

The challenge of delivering RNA-interference therapeutics to their target cells

Bianca Nogrady

Nature, 2019, vol. 574, issue 7778, S8-S9

Abstract: Delivery difficulties brought the nascent research field to its knees, but approval of the first RNA interference drug offers hope.

Keywords: Therapeutics; Non-coding RNAs (search for similar items in EconPapers)
Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-019-03071-9 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:574:y:2019:i:7778:d:10.1038_d41586-019-03071-9

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-019-03071-9

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:nature:v:574:y:2019:i:7778:d:10.1038_d41586-019-03071-9